Of the more than 7.7 million people estimated to be living with sickle cell disease, more than 80% were in sub-Saharan Africa ...

For columnist Mary Shaniqua, one of the hardest aspects of sickle cell is its unpredictability, such as the sudden onset of a ...

Columnist Oluwatosin Adesoye discusses the ongoing dilemma with sickle cell pain management for both patients and healthcare ...

Orna Therapeutics is partnering with Vertex Pharmaceuticals to develop gene-editing therapies for people with sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). The three-year ...